Correlation between chemotherapy response score (CRS) and germline BRCA1/2 (gBRCA) status in women diagnosed with FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC)

被引：0
|
作者：
Netto, D. [1 ]
Wang, X. [2 ]
Barnes, B. [3 ]
Clamp, A. R. [1 ]
Hasan, J. [1 ]
Mitchell, C. L. [1 ]
Salih, Z. [1 ]
Winter-Roach, B. [4 ]
Edmondson, R. [3 ]
Shaw, J. [5 ]
Desai, S. [6 ]
Schlecht, H. [7 ]
Burghel, G. J. [8 ]
Taylor, S. [9 ]
Evans, G. [10 ]
Jayson, G. C. [11 ]
Morgan, R. D. [1 ]
机构：
[1] Christie NHS Fdn Trust, Med Oncol Dept, Manchester, Lancs, England
[2] Christie NHS Fdn Trust, Stat, Manchester, Lancs, England
[3] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[4] Christie NHS Fdn Trust, Surg Oncol, Manchester, Lancs, England
[5] Manchester Univ NHS Fdn Trust, Histopathol, Manchester, Lancs, England
[6] Christie NHS Fdn Trust, Pathol, Manchester, Lancs, England
[7] Manchester Univ NHS Fdn Trust, Genom, Wythenshawe Hosp, Manchester, Lancs, England
[8] GLH North West Genom Lab Hub, North West Genom Lab Hyb, Manchester, Lancs, England
[9] Univ Manchester, Manchester Canc Res Ctr, Manchester, Lancs, England
[10] Manchester Univ NHS Fdn Trust, Clin Genet, Manchester, Lancs, England
[11] Univ Manchester, Med Oncol, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
782P
引用
收藏
页码：S527 / S528
页数：2
相关论文
共 50 条
  • [31] Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer
    Lee, Juhun
    Kim, Jong Mi
    Lee, Yoon Hee
    Chong, Gun Oh
    Lee, Nan Young
    Lee, In Hee
    Park, Ji Young
    Hong, Dae Gy
    IN VIVO, 2022, 36 (04): : 1903 - 1910
  • [32] P-cadherin prognostic significance in high-grade serous ovarian cancer wildtype for BRCA1/2
    Canario, R.
    Peixoto, A.
    Pinto, P.
    Guerra, J.
    Barbosa, A.
    Bartosch, C.
    Teixeira, M. R.
    Paredes, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S751 - S751
  • [33] Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer
    Boyarskikh, Ulyana A.
    Gulyaeva, L. F.
    Avdalyan, A. M.
    Kechin, A. A.
    Khrapov, E. A.
    Lazareva, D. G.
    Kushlinskii, N. E.
    Melkonyan, A.
    Arakelyan, A.
    Filipenko, Maxim Leonidovich
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] MYC Gene Amplification in High-Grade Serous Ovarian Carcinoma and its Association with BRCA1/2 Mutation Status
    Ruiz-Cordero, Roberto
    George, Sophia
    Schlumbrecht, Matthew
    de Haydu, Christopher
    Campuzano, German
    Pinto, Andre
    LABORATORY INVESTIGATION, 2018, 98 : 449 - 450
  • [35] Underestimation of Risk of a BRCA1 or BRCA2 Mutation in Women With High-Grade Serous Ovarian Cancer by BRCAPRO: A Multi-Institution Study
    Daniels, Molly S.
    Babb, Sheri A.
    King, Robin H.
    Urbauer, Diana L.
    Batte, Brittany A. L.
    Brandt, Amanda C.
    Amos, Christopher I.
    Buchanan, Adam H.
    Mutch, David G.
    Lu, Karen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) : 1249 - +
  • [36] MYC Gene Amplification in High-Grade Serous Ovarian Carcinoma and its Association with BRCA1/2 Mutation Status
    Ruiz-Cordero, Roberto
    George, Sophia
    Schlumbrecht, Matthew
    de Haydu, Christopher
    Campuzano, German
    Pinto, Andre
    MODERN PATHOLOGY, 2018, 31 : 449 - 450
  • [37] Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
    Morgan, Robert D. D.
    Burghel, George J. J.
    Flaum, Nicola
    Bulman, Michael
    Smith, Philip
    Clamp, Andrew R. R.
    Hasan, Jurjees
    Mitchell, Claire L. L.
    Salih, Zena
    Woodward, Emma R. R.
    Lalloo, Fiona
    Crosbie, Emma J. J.
    Edmondson, Richard J. J.
    Schlecht, Helene
    Jayson, Gordon C. C.
    Evans, D. Gareth R.
    CANCERS, 2023, 15 (03)
  • [38] Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy
    Lee, Young Joo
    Shin, Yoon Kyung
    Kim, Nae Ry
    Kim, Se Ik
    Lee, Yoo-Young
    Park, Jeong-Yeol
    Kim, Jae-Weon
    Cho, Hyun-Woong
    Lee, Jung-Yun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (06)
  • [39] Underestimation of risk of BRCA1/BRCA2 mutations by the BRCAPRO model in women with high-grade ovarian cancer
    Daniels, M.
    Pearson, L.
    Urbauer, D.
    Brandt, A.
    Solomon, K.
    Amos, C.
    Lu, K.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S99 - S99
  • [40] Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score
    McNulty, Meabh
    Das, Adarsh
    Cohen, Paul A.
    Dean, Andrew
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (05) : 929 - 934
12345